Difference between revisions of "About-cancer/treatment/drugs/peginterferon-alfa-2b"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Peginterferon Alfa-2b == | + | == Peginterferon Alfa-2b == <!--T:1--> |
| + | <!--T:2--> | ||
This page contains brief information about peginterferon alfa-2b and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about peginterferon alfa-2b and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
PEG-Intron | PEG-Intron | ||
| + | <!--T:5--> | ||
Sylatron | Sylatron | ||
| + | <!--T:6--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:7--> | ||
Yes | Yes | ||
| + | <!--T:8--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:9--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:10--> | ||
Peginterferon alfa-2b is approved to treat: | Peginterferon alfa-2b is approved to treat: | ||
| + | <!--T:11--> | ||
*'''Melanoma.''' It is used as adjuvant therapy in patients who have had surgery to remove cancer that has spread to the lymph nodes. This use is approved for the Sylatron brand of peginterferon alfa-2b. | *'''Melanoma.''' It is used as adjuvant therapy in patients who have had surgery to remove cancer that has spread to the lymph nodes. This use is approved for the Sylatron brand of peginterferon alfa-2b. | ||
| + | <!--T:12--> | ||
Peginterferon alfa-2b is also approved to treat chronic hepatitis C. This use is approved for the PEG-Intron brand of peginterferon alfa-2b. | Peginterferon alfa-2b is also approved to treat chronic hepatitis C. This use is approved for the PEG-Intron brand of peginterferon alfa-2b. | ||
| + | <!--T:13--> | ||
Peginterferon alfa-2b is also being studied in the treatment of other types of cancer. | Peginterferon alfa-2b is also being studied in the treatment of other types of cancer. | ||
| + | <!--T:14--> | ||
'''More About Peginterferon Alfa-2b''' | '''More About Peginterferon Alfa-2b''' | ||
| + | <!--T:15--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:16--> | ||
MedlinePlus Information on Peginterferon Alfa-2b - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Peginterferon Alfa-2b - A lay language summary of important information about this drug that may include the following: | ||
| + | <!--T:17--> | ||
*warnings about this drug, | *warnings about this drug, | ||
| + | <!--T:18--> | ||
*what this drug is used for and how it is used, | *what this drug is used for and how it is used, | ||
| + | <!--T:19--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
| + | <!--T:20--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
| + | <!--T:21--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
| + | <!--T:22--> | ||
*possible side effects. | *possible side effects. | ||
| + | <!--T:23--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
| + | <!--T:24--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:25--> | ||
Find Clinical Trials for Peginterferon Alfa-2b - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Peginterferon Alfa-2b - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:26--> | ||
'''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> | ||
Latest revision as of 21:38, 29 October 2019
Peginterferon Alfa-2b
This page contains brief information about peginterferon alfa-2b and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
PEG-Intron
Sylatron
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Peginterferon alfa-2b is approved to treat:
- Melanoma. It is used as adjuvant therapy in patients who have had surgery to remove cancer that has spread to the lymph nodes. This use is approved for the Sylatron brand of peginterferon alfa-2b.
Peginterferon alfa-2b is also approved to treat chronic hepatitis C. This use is approved for the PEG-Intron brand of peginterferon alfa-2b.
Peginterferon alfa-2b is also being studied in the treatment of other types of cancer.
More About Peginterferon Alfa-2b
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Peginterferon Alfa-2b - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Peginterferon Alfa-2b - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
